Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Solid Biosciences Inc (SLDB)  
$10.42 0.42 (4.2%) as of 4:30 Tue 5/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 19,560,000
Market Cap: 203.82(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.89 - $14.75
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 21.3
Insider 3/6 Months : 21.9
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Solid Biosciences is engaged in curing Duchenne muscular dystrophy (Duchenne), a genetic muscle-wasting disease predominantly affecting boys. SGT-001 and SGT-003 are Co.'s gene transfer candidates. SGT-001 and SGT-003 are designed to address the underlying genetic cause of Duchenne by delivering a synthetic transgene that produces dystrophin-like protein that is only expressed in muscles of the body, including cardiac and respiratory muscles. Co.'s SGT-001 and SGT-003 vectors are derived from a naturally occurring, non-pathogenic virus called adeno-associated virus, which were selected for their ability to enter skeletal, diaphragm and cardiac muscle tissues.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 4,314,873 4,314,873 4,314,873
Total Buy Value $0 $23,861,248 $23,861,248 $23,861,248
Total People Bought 0 2 2 2
Total Buy Transactions 0 2 2 2
Total Shares Sold 462 35,539 35,539 37,990
Total Sell Value $4,772 $126,957 $126,957 $144,031
Total People Sold 1 7 7 8
Total Sell Transactions 1 9 9 13
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 131
  Page 3 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Smith Ian F Director   –       •      –    2022-04-03 4 OE $0.00 $0 D/D 24,313 294,583     -
   Schneider Joel Solomon Zev Chief Operating Officer   •       –      –    2022-03-14 4 AS $1.10 $33,554 D/D (30,504) 236,270 -30%     
   Morris Carl Ashley Chief Scientific Officer   •       –      –    2022-03-14 4 AS $1.10 $24,932 D/D (22,665) 255,209 -30%     
   Ganot Ilan CEO & President   •       •      –    2022-02-10 4 AS $1.12 $519 I/I (463) 2,518 -52%     
   Koppel Adam Director   –       •      –    2021-03-23 4 A $5.75 $4,999,999 I/I 869,565 7,929,918     -
   Edelman Joseph Director   –       •       •   2021-03-23 4 B $5.75 $14,999,996 I/I 2,608,695 13,412,552 2.25 -50%     
   Shah Rajeev M. Director   –       •       •   2021-03-19 4 B $5.75 $12,688,439 I/I 2,206,685 10,916,567 2.25 -52%     
   Morris Carl Ashley Chief Scientific Officer   •       –      –    2021-03-12 4 AS $8.84 $206,947 D/D (23,398) 275,602 -69%     
   Schneider Joel Solomon Zev Chief Operating Officer   •       –      –    2021-03-12 4 AS $8.84 $206,920 D/D (23,398) 268,774 -69%     
   Ganot Ilan CEO & President   •       •      –    2021-02-12 4 S $7.66 $3,501 I/I (457) 3,026 50%     
   Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy   •       –      –    2021-01-28 4 S $6.14 $21,327 D/D (3,473) 335,636 37%     
   Schneider Joel Solomon Zev Chief Technology Officer   •       –      –    2021-01-28 4 S $6.14 $21,145 D/D (3,443) 292,172 37%     
   Morris Carl Ashley Chief Scientific Officer   •       –      –    2021-01-28 4 S $6.14 $21,238 D/D (3,459) 299,000 37%     
   Ganot Ilan CEO & President   •       •      –    2021-01-28 4 S $6.14 $65,776 D/D (10,713) 1,199,821 37%     
   Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy   •       –      –    2021-01-27 4 OE $0.00 $0 D/D 11,500 339,109     -
   Schneider Joel Solomon Zev Chief Technology Officer   •       –      –    2021-01-27 4 OE $0.00 $0 D/D 11,500 295,615     -
   Morris Carl Ashley Chief Scientific Officer   •       –      –    2021-01-27 4 OE $0.00 $0 D/D 11,500 302,459     -
   Ganot Ilan CEO & President   •       •      –    2021-01-27 4 OE $0.00 $0 D/D 35,500 1,210,534     -
   Kolchinsky Peter Director   –       •       •   2020-12-10 3 IO $0.00 $0 I/I 0 8,709,882 32%     
   Edelman Joseph 10% Owner   –       –       •   2020-12-10 4 A $3.70 $15,000,000 I/I 4,054,054 10,803,857     -
   Arnold Matthew Bennett Director   –       •      –    2020-12-10 4 A $3.70 $1,599,998 D/D 432,432 3,933,429     -
   Ganot Ilan CEO & President   •       •      –    2020-12-10 4 A $3.70 $100,000 D/D 27,027 1,175,034     -
   Smith Ian F Director   –       •      –    2020-12-10 4 A $3.70 $999,999 D/D 270,270 270,270     -
   Shah Rajeev M. Director   –       •       •   2020-12-10 4 A $3.70 $18,271,643 I/I 4,938,282 8,709,882     -
   Koppel Adam Director   –       •      –    2020-12-10 4 A $3.70 $11,799,999 I/I 3,189,189 7,060,353     -
  131 Records found
  1  2  3  4  5  6   
  Page 3 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us